SCHEDULE 13G TARGETED GENETICS

Company

Armata Pharmaceuticals, Inc.

Filed

February 4, 1997

Accession Number

0000893220-97-000221

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →